NEW YORK (Reuters Health) – An updated guideline from the American Academy of Neurology recommends plasmapheresis for severe relapses in multiple sclerosis and other inflammatory demyelinating neurologic disorders.…
NEW YORK (Reuters Health) – Depending on the particular regimen, insulin analogs can help 35% to 64% of patients with type 2 diabetes achieve the recommended hemoglobin A1C…
NEW YORK (Reuters Health) – Patients with ST-elevation myocardial infarction (STEMI) who present 12 to 24 hours after onset of symptoms should be considered for reperfusion by primary…
NEW YORK (Reuters Health) – For conversion of recent-onset atrial fibrillation, vernakalant acted more rapidly and was more effective than amiodarone in an international study. As reported in…
NEW YORK (Reuters Health) – Premature infants of < 34 weeks’ gestation on respiratory support should not be treated with inhaled nitric oxide, according to a new consensus…
NEW YORK (Reuters Health) – Dabigatran (Pradaxa, Boehringer Ingelheim) is as effective as warfarin in preventing stroke and systemic embolism after cardioversion in patients with nonvalvular atrial fibrillation,…
Doctors often prescribe unfractionated heparin to obese patients with venous thromboembolism below the recommended doses based on body weight, according to a new study. As a result, some…
NEW YORK (Reuters Health) – Patients with pneumonia and blood oxygen saturation less than 90% are usually hospitalized. Yet, results of new study suggest that the threshold for…
NEW YORK (Reuters Health) – The authors of a systematic review and meta-analysis of relevant studies encourage clinicians to exercise good judgment in using the injectable antibiotic tigecycline…
NEW YORK (Reuters Health) – In patients with chronic stable heart failure (HF) due to nonischemic dilated cardiomyopathy, a year’s treatment with n-3 polyunsaturated fatty acids (n-3 PUFAs)…